-
Mashup Score: 0Viral medical memes - Rheuma - 5 year(s) ago
The very best and worst the internet has to offer in medical memes.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0The ongoing belimumab disappointment - Rheuma - 5 year(s) ago
Rheumatologists had high hopes for belimumab as the first lupus biologic, but despite even more positive data coming out of the BLISS-LN trial presented at EULAR, access remains an issue in Australia.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0RA by numbers: AIHW releases updated report - Rheuma - 5 year(s) ago
The latest figures from the Australian Institute of Health and Welfare, published last month in an updated report, highlight the burden of this disease among Australians of all ages.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0What are COVID’s longterm complications? - Rheuma - 5 year(s) ago
Chronic cough, lung fibrosis, fatigue and dyspnoea could be in store for those who recover from a bad bout.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
The elevated risk among AS patients of sustaining a spinal fracture has not changed in 35 years, even after the introduction of TNFi, an Australian cohort study finds.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Clinical case report of Cimzia® (certolizumab pegol) for the treatment of non-radiographic axial spondyloarthritis - Rheuma - 5 year(s) ago
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease that affects the axial skeleton, characterised by chronic lower back pain with peripheral manifestations including arthritis, enthesitis, and dactylitis.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0Too much faith put in imaging for low back pain - Rheuma - 5 year(s) ago
Discussing the potential harms may help address patient expectations, experts say
Source: RheumaCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 1
The FDA has requested more safety data on filgotinib, an advanced drug candidate for RA, stalling its progress to approval that has so far been bankrolled by pharmaceutical giant, Gilead.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
Security guards recruited via WhatsApp are being used as cover for a state healthcare system that has been exposed by COVID-19 as antiquated, broken and in dire need of reform.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet
-
Mashup Score: 0
Security guards recruited via WhatsApp are being used as cover for a state healthcare system that has been exposed by COVID-19 as antiquated, broken and in dire need of reform.
Source: RheumaCategories: Latest Headlines, RheumatologyTweet
The darkest and brightest of this week’s medical memes. https://t.co/X2yqWVI2uT